AI Imaging & Diagnostics Market Report – Research, Industry Analysis Reports and Market Demands

Global AI Imaging & Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global AI Imaging & Diagnostics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of AI Imaging & Diagnostics by Company Revenue
- 3.2.2 Top 3 AI Imaging & Diagnostics Players Market Share in 2025
- 3.2.3 Top 6 AI Imaging & Diagnostics Players Market Share in 2025
3.3 AI Imaging & Diagnostics Market: Overall Company Footprint Analysis
- 3.3.1 AI Imaging & Diagnostics Market: Region Footprint
- 3.3.2 AI Imaging & Diagnostics Market: Company Product Type Footprint
- 3.3.3 AI Imaging & Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global AI Imaging & Diagnostics Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Imaging & Diagnostics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Imaging & Diagnostics Market Forecast by Application (2027-2032)

6 North America

6.1 North America AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
6.2 North America AI Imaging & Diagnostics Market Size by Application (2021-2032)
6.3 North America AI Imaging & Diagnostics Market Size by Country
- 6.3.1 North America AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
- 6.3.2 United States AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 6.3.3 Canada AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 6.3.4 Mexico AI Imaging & Diagnostics Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
7.2 Europe AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
7.3 Europe AI Imaging & Diagnostics Market Size by Country
- 7.3.1 Europe AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
- 7.3.2 Germany AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 7.3.3 France AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 7.3.5 Russia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 7.3.6 Italy AI Imaging & Diagnostics Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Imaging & Diagnostics Market Size by Region
- 8.3.1 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Region (2021-2032)
- 8.3.2 China AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 8.3.3 Japan AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 8.3.4 South Korea AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 8.3.5 India AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 8.3.7 Australia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)

9 South America

9.1 South America AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
9.2 South America AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
9.3 South America AI Imaging & Diagnostics Market Size by Country
- 9.3.1 South America AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
- 9.3.2 Brazil AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 9.3.3 Argentina AI Imaging & Diagnostics Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Imaging & Diagnostics Market Size by Country
- 10.3.1 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
- 10.3.2 Turkey AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
- 10.3.4 UAE AI Imaging & Diagnostics Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 AI Imaging & Diagnostics Market Drivers
11.2 AI Imaging & Diagnostics Market Restraints
11.3 AI Imaging & Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 AI Imaging & Diagnostics Industry Chain
12.2 AI Imaging & Diagnostics Upstream Analysis
12.3 AI Imaging & Diagnostics Midstream Analysis
12.4 AI Imaging & Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global AI Imaging & Diagnostics market size was valued at US$ 7469 million in 2025 and is forecast to a readjusted size of US$ 27568 million by 2032 with a CAGR of 20.4% during review period.
AI Imaging & Diagnostics refers to the integrated market of artificial intelligence technologies applied to medical imaging analysis and broader clinical diagnostic decision-making. It includes AI systems that analyze imaging data such as X-ray, CT, MRI, ultrasound, mammography, and digital pathology, as well as solutions that combine imaging with non-imaging clinical inputs (e.g., physiological signals, structured EHR data) to support diagnosis. These products are typically commercialized as regulated Software as a Medical Device (SaMD) or embedded into imaging equipment and clinical IT systems such as PACS, RIS, and EHRs. AI Imaging & Diagnostics enhances diagnostic accuracy, standardization, and efficiency while keeping physicians in the loop, addressing rising imaging volumes, workforce shortages, and the need for earlier and more consistent disease detection.
The market can be classified by data type (imaging-based, signal-based, multi-modal), by clinical function (detection, segmentation, classification, severity scoring, diagnostic recommendation), by medical specialty (radiology, cardiology, oncology, neurology, ophthalmology, primary care), by deployment model (on-premise, cloud SaaS, device-embedded, edge-based), and by regulatory/commercial type (standalone SaMD, bundled software, clinical decision support, screening-focused solutions). These dimensions reflect both technical complexity and commercial pathways.
Key costs arise from data acquisition and labeling, algorithm development, clinical trials, regulatory compliance, and continuous model updates. With software-centric economics, gross margins generally range from 65% to 80%. Transactions are dominated by subscription SaaS, per-study pricing, and multi-year enterprise licenses, often bundled with imaging systems or workflow platforms. Market trends include rapid regulatory approvals, consolidation through M&A, deeper OEM integration, expansion beyond radiology into multi-disciplinary diagnostics, and accelerating adoption driven by value-based care and clinician shortages.
This report is a detailed and comprehensive analysis for global AI Imaging & Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Imaging & Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Imaging & Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Imaging & Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical, BrainMiner, GE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Imaging & Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
X-ray / CXR
CT
MRI
Ultrasound
Mammography / DBT
Others
Market segment by Diagnostic Data Type
Medical Imaging–based
Physiological Signals–based
Ophthalmic Imaging–based
Others
Market segment by Deployment & Delivery
On-prem
Cloud SaaS
Edge / Embedded
Hybrid
Others
Market segment by Application
Radiology & Imaging
Cardiology
Neurology
Ophthalmology
Oncology
Primary Care
Others
Market segment by players, this report covers
Butterfly Network
Merative
Tempus
RetinAi
Nanox
Lunit
DiA Imaging
Subtle Medical
BrainMiner
GE
Siemens
Aidoc
Imagen Technologies, Inc.
VUNO, Inc.
Digital Diagnostics
NeuraSignal
Riverain Technologies, LLC
Philips
Microsoft
Viz.ai
RapidAI
Canon Medical
Enlitic
BioMind
ANNALISE-AI PTY LTD
icometrix
KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Imaging & Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Imaging & Diagnostics, with revenue, gross margin, and global market share of AI Imaging & Diagnostics from 2021 to 2026.
Chapter 3, the AI Imaging & Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Imaging & Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Imaging & Diagnostics.
Chapter 13, to describe AI Imaging & Diagnostics research findings and conclusion.

Buy now